Literature DB >> 10986306

Nitric oxide is a mediator of apoptosis in the rheumatoid joint.

R J van't Hof1, L Hocking, P K Wright, S H Ralston.   

Abstract

OBJECTIVE: To study the role of nitric oxide (NO) derived from the inducible nitric oxide synthase (iNOS) pathway in the induction of apoptosis in the rheumatoid joint.
METHODS: Joint tissue was obtained from four rheumatoid arthritis (RA) patients, three osteoarthritis patients and two patients with a fractured neck of the femur (NOF#), and apoptotic cells were identified in cryosections using the TUNEL (terminal dUTP nick end labelling) assay. Expression of iNOS was determined using immunohistochemistry. NO synthesis and the effect of NOS inhibitors on apoptosis levels were studied in explant cultures of RA cartilage and synovium.
RESULTS: Numbers of apoptotic cells were greatly increased in rheumatoid synovium and articular cartilage compared with NOF# and osteoarthritic synovium. Immunohistochemistry showed co-localization of iNOS staining and apoptosis in the synovial lining layer and articular cartilage. The NOS inhibitor L-NMMA (L-N(G)-monomethylarginine) strongly inhibited apoptosis in explant cultures of synovium and cartilage, and this was reversed by the NO donor S-nitroso-acetyl-penicillamine.
CONCLUSION: This study indicates that NO acts as a mediator of apoptosis in RA and suggests that NOS inhibitors reverse this process.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10986306     DOI: 10.1093/rheumatology/39.9.1004

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN: 1462-0324            Impact factor:   7.580


  22 in total

Review 1.  Nitric oxide and bone.

Authors:  R J van't Hof; S H Ralston
Journal:  Immunology       Date:  2001-07       Impact factor: 7.397

2.  Reply: To PMID 25882860.

Authors:  Qiang Li; Ji-Youn Youn; Shan Li; Hua Cai
Journal:  J Hypertens       Date:  2015-11       Impact factor: 4.844

3.  Calreticulin promotes angiogenesis via activating nitric oxide signalling pathway in rheumatoid arthritis.

Authors:  H Ding; C Hong; Y Wang; J Liu; N Zhang; C Shen; W Wei; F Zheng
Journal:  Clin Exp Immunol       Date:  2014-11       Impact factor: 4.330

Review 4.  Molecular basis of oxidative stress in gouty arthropathy.

Authors:  Yessica Zamudio-Cuevas; Cristina Hernández-Díaz; Carlos Pineda; Anthony M Reginato; Jorge Francisco Cerna-Cortés; Lucio Ventura-Ríos; Alberto López-Reyes
Journal:  Clin Rheumatol       Date:  2015-04-09       Impact factor: 2.980

5.  Interleukin-1beta induces death in chondrocyte-like ATDC5 cells through mitochondrial dysfunction and energy depletion in a reactive nitrogen and oxygen species-dependent manner.

Authors:  Rika Yasuhara; Yoichi Miyamoto; Takaaki Akaike; Teruo Akuta; Masanori Nakamura; Masamichi Takami; Naoko Morimura; Kayoko Yasu; Ryutaro Kamijo
Journal:  Biochem J       Date:  2005-07-15       Impact factor: 3.857

6.  Polymorphisms of the eNOS gene are associated with disease activity in rheumatoid arthritis.

Authors:  Vera Bunjevacki; Nela Maksimovic; Biljana Jekic; Vera Milic; Ljiljana Lukovic; Ivana Novakovic; Nemanja Damjanov; Goran Radunovic; Tatjana Damnjanovic
Journal:  Rheumatol Int       Date:  2015-11-26       Impact factor: 2.631

7.  Associations between eNOS polymorphisms and susceptibility to systemic lupus erythematosus and rheumatoid arthritis: a meta-analysis.

Authors:  Y H Lee; S-C Bae
Journal:  Z Rheumatol       Date:  2017-10       Impact factor: 1.372

8.  Synovial fluid nitric oxide levels in patients with knee osteoarthritis.

Authors:  Ayşe Karan; Mehmet Akif Karan; Pervin Vural; Nilgün Erten; Cemil Taşçioğlu; Cihan Aksoy; Mukaddes Canbaz; Ahmet Oncel
Journal:  Clin Rheumatol       Date:  2003-10-18       Impact factor: 2.980

9.  Effect and mechanism of AR-6 in experimental rheumatoid arthritis.

Authors:  Shi-xue Sun; Yun-man Li; Wei-rong Fang; Peng Cheng; Lifang Liu; Fengwen Li
Journal:  Clin Exp Med       Date:  2009-10-20       Impact factor: 3.984

10.  Active leflunomide metabolite inhibits interleukin 1beta, tumour necrosis factor alpha, nitric oxide, and metalloproteinase-3 production in activated human synovial tissue cultures.

Authors:  O Elkayam; I Yaron; I Shirazi; R Judovitch; D Caspi; M Yaron
Journal:  Ann Rheum Dis       Date:  2003-05       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.